ArticleInternational journal of preventive medicine2026
Benefit of Psyllium with Weight Loss Diet in Preventing Liver Dysfunction in Overweight or Obese Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Article in International journal of preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: MASLD is the revised nomenclature of nonalcoholic fatty liver disease (NAFLD) which is the most common chronic liver disease worldwide and it significantly impacts the burden of the disease. Individuals who are overweight or obese have three times higher risk of developing MASLD. Losing body weight is, therefore, recommended to manage MASLD. This study was performed to assess the effect of psyllium on liver function in overweight or obese adults with (MASLD). Methods: We assessed 80 overweight or obese MASLD patients diagnosed by elastography. They were divided into intervention and placebo groups through randomized block design. Intervention group was given 10 grams of psyllium and the control group was given 10 grams of ground wheat as supplement. Weight loss diet and physical activity (PA) recommendations were followed by both groups for 10 weeks. Serum liver enzymes, liver function (measured by fibroscan), PA, and dietary intake were assessed pre- and post-intervention. Results: Totally, 78 participants finished the RCT. After controlling confounding variables, intake of calorie ( Conclusions: Psyllium can be introduced as a dietary supplement that exerts beneficial role in gut health, weight loss, and preventing MASLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.